| Literature DB >> 24509131 |
Joan A Casey1, Bo Shopsin, Sara E Cosgrove, Keeve E Nachman, Frank C Curriero, Hannah R Rose, Brian S Schwartz.
Abstract
BACKGROUND: European studies suggest that living near high-density livestock production increases the risk of sequence type (ST) 398 methicillin-resistant Staphylococcus aureus (MRSA) colonization. To our knowledge, no studies have evaluated associations between livestock production and human infection by other strain types.Entities:
Mesh:
Year: 2014 PMID: 24509131 PMCID: PMC4014753 DOI: 10.1289/ehp.1307370
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Figure 1High-density livestock production and MRSA infection, Geisinger Health Care System, Pennsylvania.
Patients identified and included in the present analysis according to MRSA subtype and exposure in their residential ZIP code.
| Group | High-density livestock production | No high-density livestock production | Total |
|---|---|---|---|
| CO-MRSA | |||
| Patients included [ | 70 (42.2) | 96 (57.8) | 166 |
| Total patients [ | 321 (32.5) | 667 (67.5) | 988 |
| Sample weight | 4.59 | 6.95 | |
| HO-MRSA | |||
| Patients included [ | 11 (36.7) | 19 (63.3) | 30 |
| Total patients [ | 54 (22.5) | 186 (77.5) | 240 |
| Sample weight | 4.91 | 9.79 | |
| Total patients included ( | 81 | 115 | 196 |
| Total patients identified ( | 375 | 853 | 1,128 |
| Abbreviations: CO, community-onset; HO, hospital-onset. | |||
Onset location, Ridom spa types, and PVL presence by MRSA subgroup [n (%)].
| Characteristic | CO-PVL-negative | All other MRSA ( | |
|---|---|---|---|
| CO-MRSA | 23 (100) | 12 (80.0) | 135 (83.3) |
| CC5 or CC5-like | |||
| t002 | 9 (39.1) | 1 (6.7) | 17 (10.5) |
| t010 | 2 (8.7) | 0 | 0 |
| t045 | 0 | 1 (6.7) | 1 (0.6) |
| t062 | 1 (4.3) | 0 | 0 |
| t088 | 3 (13.0) | 1 (6.7) | 0 |
| t105 | 1 (4.3) | 1 (6.7) | 2 (1.2) |
| t306 | 1 (4.3) | 0 | 0 |
| t6614 | 1 (4.3) | 1 (6.7) | 0 |
| Other | 0 | 0 | 3 (1.8) |
| CC8 or CC8-like | |||
| t008 | 0 | 7 (46.7) | 115 (71.0) |
| t024 | 0 | 1 (6.7) | 6 (3.7) |
| t068 | 0 | 0 | 2 (1.2) |
| t121 | 0 | 1 (6.7) | 2 (1.2) |
| t622 | 0 | 0 | 3 (1.9) |
| Other | 0 | 0 | 7 (4.3) |
| Other CC | |||
| t125 | 1 (4.3) | 1 (6.7) | 0 |
| t948 | 1 (4.3) | 0 | 0 |
| t9964 | 1 (4.3) | 0 | 0 |
| t11970 | 1 (4.3) | 0 | 0 |
| Other | 0 | 0 | 3 (1.9) |
| Novel | 1 (4.3) | 0 | 1 (0.6) |
| PVL-positive | 0 | 9 (60.0) | 140 (86.4) |
| Percentages do not add to 100 due to rounding. | |||
Patient demographic and clinical characteristics of MRSA subgroups by swine livestock exposure quartile [data are n (%) unless otherwise indicated]
| Characteristic | CO-PVL-negative ( | All other MRSA ( | Swine (quartile) | ||||
|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | ||||
| Sex, male | 15 (65.2) | 11 (73.3) | 85 (52.5) | 28 (26.2) | 25 (23.4) | 24 (22.4) | 30 (28.0) |
| Age at infection or visit [median (interquartile range)] (years) | 54.2 (32.3–75.2) | 52.8 (14.6–75.1) | 32.8 (14.4–55.2) | 46.0 (17.3–62.4) | 33.6 (22.5–54.7) | 31.1 (9.8–51.7) | 37.5 (13.6–59.1) |
| Race/ethnicity | |||||||
| Non-Hispanic white | 22 (95.7) | 15 (100) | 155 (95.7) | 44 (23.4) | 49 (26.1) | 48 (25.5) | 47 (25.0) |
| Non-Hispanic black | 1 (4.4) | 0 | 6 (3.7) | 5 (71.4) | 0 | 0 | 2 (28.6) |
| Other | 0 | 0 | 1 (0.6) | 0 | 0 | 1 (100) | 0 |
| Never-smoker | 16 (69.6) | 10 (66.7) | 139 (85.8) | 39 (23.9) | 43 (26.4) | 40 (24.5) | 41 (25.2) |
| Season of onset | |||||||
| Winter | 7 (30.4) | 3 (20.0) | 27 (16.7) | 12 (34.3) | 7 (20.0) | 7 (20.0) | 9 (25.7) |
| Spring | 5 (21.7) | 4 (26.7) | 37 (22.8) | 16 (34.8) | 13 (28.3) | 9 (19.6) | 8 (17.4) |
| Summer | 7 (30.4) | 5 (33.3) | 39 (24.1) | 10 (20.4) | 16 (32.7) | 12 (24.5) | 11 (22.5) |
| Autumn | 4 (17.4) | 3 (20.0) | 59 (36.4) | 11 (16.7) | 13 (19.7) | 21 (31.8) | 21 (31.8) |
| Antibiotic prescription in previous year | 5 (21.7) | 6 (40.0) | 65 (40.1) | 21 (27.6) | 20 (26.3) | 15 (19.7) | 20 (26.3) |
| Source | |||||||
| Skin/soft tissue | 19 (82.6) | 11 (73.3) | 141 (87.0) | 36 (25.9) | 39 (28.1) | 28 (20.1) | 36 (25.9) |
| Respiratory | 0 | 2 (13.3) | 15 (9.3) | 6 (35.3) | 4 (23.5) | 4 (23.5) | 3 (17.7) |
| Bone | 2 (8.7) | 1 (6.7) | 2 (1.2) | 1 (25.0) | 0 | 2 (50.0) | 1 (25.0) |
| Other | 2 (8.7) | 1 (6.7) | 4 (2.5) | 0 | 3 (42.9) | 2 (28.6) | 2 (28.6) |
| Antibiotic resistance | |||||||
| Clindamycin | 12 (52.2) | 2 (13.3) | 32 (19.8) | 10 (21.7) | 11 (23.9) | 13 (28.3) | 12 (26.1) |
| Erythromycin | 18 (78.3) | 12 (80.0) | 149 (92.0) | 43 (24.4) | 46 (26.1) | 46 (26.1) | 41 (23.3) |
| Tetracycline | 4 (17.4) | 1 (6.7) | 4 (2.5) | 2 (25.0) | 2 (25.0) | 2 (25.0) | 2 (25.0) |
| TMP-SMZ | 1 (4.4) | 1 (6.7) | 2 (1.2) | 2 (66.7) | 1 (33.3) | 0 | 0 |
| Multidrug | 14 (60.9) | 3 (20.0) | 33 (20.4) | 12 (24.5) | 11 (22.5) | 14 (28.6) | 12 (24.5) |
| Community type | |||||||
| City | 1 (4.4) | 0 | 23 (14.2) | 11 (45.8) | 3 (12.5) | 9 (37.5) | 1 (4.2) |
| Borough | 11 (47.8) | 5 (33.3) | 44 (27.2) | 15 (25.9) | 15 (25.9) | 8 (13.8) | 20 (34.5) |
| Township | 11 (47.8) | 10 (66.7) | 95 (58.6) | 23 (20.2) | 31 (27.2) | 32 (28.1) | 28 (24.6) |
| Medical Assistance | |||||||
| Never received | 15 (65.2) | 10 (66.7) | 127 (78.4) | 35 (23.3) | 37 (24.7) | 41 (27.3) | 37 (24.7) |
| Location of onset | |||||||
| Community | 27 (100) | 15 (83.3) | 135 (83.3) | 41 (24.7) | 43 (25.9) | 40 (24.1) | 42 (25.3) |
| Hospital | 0 | 3 (16.7) | 27 (16.7) | 8 (26.7) | 6 (20.0) | 9 (30.0) | 7 (23.3) |
| No. of patients with high-density livestock production in their residential ZIP code | 9 (39.1) | 7 (46.7) | 67 (41.4) | 1 (1.2) | 17 (21.0) | 25 (30.9) | 38 (46.9) |
| Abbreviations: previous year, 365 to 14 days before infection; TMP-SMZ, trimethoprim– sulfamethoxazole. | |||||||
Unadjusted and adjusted associations of dichotomous exposures with CO-PVL-negative MRSA and scn-negative MRSA compared with all other MRSA (n/N).
| Exposure | CO-PVL-negative | |||||
|---|---|---|---|---|---|---|
| All other MRSA ( | Unadjusted OR (95% CI) | Adjusted OR | All other MRSA ( | Unadjusted OR (95% CI) | ||
| Livestock | ||||||
| Swine (quartile) | 1, 2, 3 | 12/124 | 1.0 | 1.0 | 12/125 | 1.0 |
| 4 | 11/37 | 3.55 (1.41, 8.94) | 4.24 (1.60, 11.25) | 3/37 | 0.79 (0.20, 3.09) | |
| Dairy/veal (quartile) | 1, 2, 3 | 15/122 | 1.0 | 1.0 | 13/122 | 1.0 |
| 4 | 8/40 | 1.57 (0.61, 4.05) | 2.42 (0.85, 6.88) | 2/40 | 0.47 (0.10, 2.24) | |
| Treated crop field | ||||||
| Swine (quartile) | 1, 2, 3 | 15/121 | 1.0 | 1.0 | 14/121 | 1.0 |
| 4 | 8/41 | 1.55 (0.59, 4.05) | 2.38 (0.78, 7.28) | 1/41 | 0.18 (0.02, 1.43) | |
| Dairy/veal (quartile) | 1, 2, 3 | 14/123 | 1.0 | 1.0 | 13/123 | 1.0 |
| 4 | 9/39 | 2.28 (0.89, 5.83) | 4.88 (1.40, 17.00) | 2/39 | 0.46 (0.10, 2.20) | |
Figure 2Association of swine and dairy/veal seasonal crop field quartiles and livestock quartiles with CO-PVL-negative MRSA status from adjusted models. Adjusted for sex, age, ever-smoking status, antibiotic order in the 365 to 14 days before infection, season, and receipt of Medical Assistance. *p-Value for linear trend ≤ 0.05 (quartiles included as a single variable with values 1, 2, 3, and 4).